Kudelski SA (KUD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Kudelski SA (Kudelski) provider of digital security technologies and solutions. It provides cybersecurity services, integrated user experience and content production solutions, asset tracking solutions, and consulting services. The company provides public access solutions to maintain control over the access of people or vehicles to car parks, airports, and sports, entertainment, cultural, and exhibition facilities. Kudelski’s Digital TV category offers technologies to secure the revenue of content owners and service providers for digital television and interactive applications in broadcast, broadband, and mobile delivery networks. It also provides cybersecurity products and services to protect the assets of businesses, and security services to help companies across the IoT value chain. The company offers its services to telecom, internet, satellite, automotive, and mobile operators, content providers, and broadcasters. It also develops and provides device security, and data security platforms for IoT technology. The company operates across Europe, the US, Africa, the Middle East and Asia-Pacific regions. Kudelski is headquartered in Cheseaux-sur-Lausanne, Switzerland.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
Lonza Group Ltd - Key Facts
Lonza Group Ltd - Key Employees
Lonza Group Ltd - Key Employee Biographies
Lonza Group Ltd - Major Products and Services
Lonza Group Ltd - History
Lonza Group Ltd - Company Statement
Lonza Group Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 - Company Analysis
Company Overview
Lonza Group Ltd - Business Description
Business Segment: Advanced Synthesis
Overview
Performance
Key Stats
Business Segment: Corporate
Performance
Business Segment: Integrated Biologics
Overview
Performance
Key Stats
Business Segment: Specialized Modalities
Overview
Performance
Key Stats
Geographical Segment: Asia
Performance
Geographical Segment: Australia & New Zealand
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North and Central America
Performance
Geographical Segment: Other Countries
Performance
R&D Overview
Lonza Group Ltd - Corporate Strategy
Lonza Group Ltd - SWOT Analysis
SWOT Analysis - Overview
Lonza Group Ltd - Strengths
Lonza Group Ltd - Weaknesses
Lonza Group Ltd - Opportunities
Lonza Group Ltd - Threats
Lonza Group Ltd - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Lonza Group Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
May 20, 2026: Lonza Capsugel Strengthens Global Renewable Energy Strategy With Local Wind Power Agreement
May 20, 2026: Lonza and Oxford Nanopore Technologies Launch Direct RNA Sequencing Solution for GMP mRNA Quality Control
May 09, 2026: Rapid Host Screening and Early Protein Expression
May 09, 2026: Epibase In Vitro and In Silico Screening for Biotherapeutics
May 09, 2026: Immunogenicity and Immunotoxicity Assessment
May 09, 2026: Lonza Early Development Services for Bioconjugates
May 09, 2026: Recombinant Proteins and Scaffolds
May 09, 2026: High-Throughput Experimentation (HTE)
May 09, 2026: Ibex Design ADC DNA-to-IND Program
Mar 31, 2026: Lonza Nominates Stephen Fry as Independent Board Member
Section 6 - Appendix
Methodology
Ratio Definitions
About the Analyst
Contact the Publisher
Disclaimer
List of Tables
Lonza Group Ltd, Key Facts
Lonza Group Ltd, Key Employees
Lonza Group Ltd, Key Employee Biographies
Lonza Group Ltd, Major Products and Services
Lonza Group Ltd, History
Lonza Group Ltd, Other Locations
Lonza Group Ltd, Subsidiaries
Lonza Group Ltd, Joint Venture
Lonza Group Ltd, Key Competitors
Lonza Group Ltd, Ratios based on current share price
Lonza Group Ltd, Annual Ratios
Lonza Group Ltd, Interim Ratios
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Lonza Group Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Lonza Group Ltd, Performance Chart (2021 - 2025)
Lonza Group Ltd, Ratio Charts
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Lonza Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net